Skip to main content

Trevor G. Hackman, MD, FACS

Vice Chair of Inpatient Operations and Improvement Director | Head and Neck Oncology Fellowship | Associate Professor

Director, Head and Neck Oncology Fellowship

Specialty:

Head and neck surgical oncology, endocrine surgery, parotid surgery, transoral laser microsurgery, open and endoscopic skull base surgery, head and neck reconstruction, minimally invasive head and neck surgery, sinus surgery.

Contact Information:

  • Appointments: (984) 974-0000
  • Surgery Scheduler: Patricia Longest (919) 966-7491
  • Administrative Coordinator: Anna Covington (919) 966-8927

Education:

  • MD: University of Pittsburgh, 2003
  • Internship, General Surgery, University of Pittsburgh, 2003-2004
  • Residency: Otolaryngology, University of Pittsburgh, 2004-2008
  • Fellowship: Head and Neck/Microvascular, Washington University – St. Louis, 2008-2009

Professional Experience:

  • Associate Professor, Department of Otolaryngology/Head and Neck Surgery, University of North Carolina, 2015-present
  • Assistant Professor, Department of Otolaryngology/Head and Neck Surgery, University of North Carolina, 2009-2015

Recent Publications:

For a complete list of recent publications, please visit Dr. Hackman’s PubMed listing.

Open Studies:

  • 09-2146 Treatment Outcomes of Patients with Head and Neck Cancer at the University of North Carolina, Chapel Hill Approved 6/11/2017
  • 11-0289 LCCC 1037: Accuracy of Ultrasound Guided FNA in Detecting Persistent Dis-ease in Lymph Nodes of Patients with Head and Neck Squamous Cell Carcinoma after Defini-tive Chemoradiotherapy Completed 3/18/2013
  • 11-0381 RTOG 1008: A Randomized Phase II/Phase III Study of Adjuvant Concurrent Ra-diation and Chemotherapy Versus Radiation Alone in Resected High-Risk Malignant Salivary Gland Tumors Approved 10/23/2017
  • 11-1688 The Effects of Nutrition on Postoperative Morbidity in Head and Neck Cancer Pa-tients Exempt
  • 12-0646 RTOG 0920: A Phase III Study of Postoperative Radiation Therapy (IMRT) +/- Cetuximab for Locally-Advanced Resected Head and Neck Cancer Approved 10/21/2017
  • 12-0851 LCCC 1125: Multimodality Risk Adapted Therapy including Car-boplatin/Paclitaxel/Lapatinib as Induction for Squamous Cell Carcinoma of the Head and Neck Amenable to Transoral Surgical Approaches Approved 3/13/2017
  • 12-1087 Usage of Different Flaps for the Reconstruction of Head and Neck
    Approved 9/20/2017
  • 13-3660 The Incidence of osteoradionecrosis in head and neck cancer patients treated with IMRT Exempt
  • 14-1795 LCCC 1413: De-intensification of Radiation and Chemotherapy for Favorable-Risk HPV-related Oropharyngeal SCCA Approved
  • 14-1926 Reliability and Accuracy of Ultrasonography for Detecting Vocal Cord Motion Approved 1/12/2017
  • 14-2037 Use of BRAF immunohistochemistry on cytologic samples of papillary thyroid carcinoma Exempt
  • 14-2968 Reconstruction of bony defects of the head and neck. Exempt
  • 15-1402 Treatment outcomes for patients with obstructive sleep apnea. Expired 9/7/2016
  • 15-3117 Cost Effectiveness of Virtual Surgical Planning Versus Usual Care in Mandibular and Maxillary Reconstruction Approved 2/16/2017
  • 16-0118 Cost comparison study of treatment of laryngeal cancer Approved 1/24/2017
  • 16-0997 Sialendoscopy Outcomes at UNC Approved 4/17/2017
  • 16-3263 Disparity in preoperative and intraoperative Parathyroid Hormone levels